These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 21220385)
1. Bremen doctors sign up to reduce drug use in ADHD patients. Stafford N BMJ; 2011 Jan; 342():d127. PubMed ID: 21220385 [No Abstract] [Full Text] [Related]
2. When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populations. Manor I; Rozen S; Zemishlani Z; Weizman A; Zalsman G Clin Neuropharmacol; 2011; 34(4):148-54. PubMed ID: 21738027 [TBL] [Abstract][Full Text] [Related]
3. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [TBL] [Abstract][Full Text] [Related]
4. Compliance with guidelines for ADHD: a pilot study of an evaluation tool. Vreeman RC; Madsen KA; Vreeman DJ; Carroll AE; Downs SM J Pediatr; 2006 Oct; 149(4):568-71. PubMed ID: 17011336 [TBL] [Abstract][Full Text] [Related]
5. [A pilot study of methylphenidate and parent training in the treatment of children with attention-deficit hiperactivity disorder]. Montiel Nava C; Peña JA; Espina Mariñes G; Ferrer-Hernandez ME; López-Rubio A; Puertas-Sánchez S; Cardozo-Durán JJ Rev Neurol; 2002 Aug 1-15; 35(3):201-5. PubMed ID: 12235578 [TBL] [Abstract][Full Text] [Related]
6. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial. Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402 [TBL] [Abstract][Full Text] [Related]
8. A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities. Rubio B; Hernández S; Verche E; Martín R; González-Pérez P Atten Defic Hyperact Disord; 2011 Mar; 3(1):13-20. PubMed ID: 21432614 [TBL] [Abstract][Full Text] [Related]
9. Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalised by stimulant treatment: a non-invasive MRI pilot study. O'Gorman RL; Mehta MA; Asherson P; Zelaya FO; Brookes KJ; Toone BK; Alsop DC; Williams SC Neuroimage; 2008 Aug; 42(1):36-41. PubMed ID: 18511306 [TBL] [Abstract][Full Text] [Related]
10. Effects of maternal stimulant medication on observed parenting in mother-child dyads with attention-deficit/hyperactivity disorder. Chronis-Tuscano A; Rooney M; Seymour KE; Lavin HJ; Pian J; Robb A; Efron L; Conlon C; Stein MA J Clin Child Adolesc Psychol; 2010; 39(4):581-7. PubMed ID: 20589568 [TBL] [Abstract][Full Text] [Related]
11. [Frequency, comorbidity and psychosocial correlates of attention-deficit/hyperactivity disorder. Results of a Bremen adolescent study]. Essau CA; Groen G; Conradt J; Turbanisch U; Petermann F Fortschr Neurol Psychiatr; 1999 Jul; 67(7):296-305. PubMed ID: 10443340 [TBL] [Abstract][Full Text] [Related]
12. Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD). Joshi K; Lad S; Kale M; Patwardhan B; Mahadik SP; Patni B; Chaudhary A; Bhave S; Pandit A Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):17-21. PubMed ID: 16314082 [TBL] [Abstract][Full Text] [Related]
13. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Konstenius M; Jayaram-Lindström N; Beck O; Franck J Drug Alcohol Depend; 2010 Apr; 108(1-2):130-3. PubMed ID: 20015599 [TBL] [Abstract][Full Text] [Related]
14. Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. Rugino TA; Copley TC J Am Acad Child Adolesc Psychiatry; 2001 Feb; 40(2):230-5. PubMed ID: 11211372 [TBL] [Abstract][Full Text] [Related]
15. Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study. Lyon MR; Cline JC; Totosy de Zepetnek J; Shan JJ; Pang P; Benishin C J Psychiatry Neurosci; 2001 May; 26(3):221-8. PubMed ID: 11394191 [TBL] [Abstract][Full Text] [Related]
16. A controlled study of autonomic nervous system function in adults with attention-deficit/hyperactivity disorder treated with stimulant medications: results of a pilot study. Schubiner H; Hassunizadeh B; Kaczynski R J Atten Disord; 2006 Nov; 10(2):205-11. PubMed ID: 17085631 [TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study. Biederman J; Mick E; Faraone S; Hammerness P; Surman C; Harpold T; Dougherty M; Aleardi M; Spencer T J Clin Psychopharmacol; 2006 Apr; 26(2):163-6. PubMed ID: 16633145 [TBL] [Abstract][Full Text] [Related]
18. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study. Cubo E; Fernández Jaén A; Moreno C; Anaya B; González M; Kompoliti K Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255 [TBL] [Abstract][Full Text] [Related]
19. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. Riggs PD; Leon SL; Mikulich SK; Pottle LC J Am Acad Child Adolesc Psychiatry; 1998 Dec; 37(12):1271-8. PubMed ID: 9847499 [TBL] [Abstract][Full Text] [Related]